Business

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Schultz brings public company healthcare finance and medical technology experience to support Nuwellis’ next phase of growthMINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as

articleBoston Scientific CorporationJanuary 30, 20263/company/boston-scientific-corp/news/nuwellis-appoints-carisa-schultz-as-chief-financial-officer
Nuwellis Appoints Carisa Schultz as Chief Financial Officer

About this update from Boston Scientific Corporation

[{"type":"image","alt":"Nuwellis, Inc.","displaySize":"","headline":null,"caption":"Nuwellis, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":72,"url":"https://media.zenfs.com/en/globenewswire.com/d2460037586c5d451999b7d63383d34b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/epm_zxode7LAVlWVBg62FQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/d2460037586c5d451999b7d63383d34b","width":300,"height":72}},"lazy":false},{"type":"text","content":"Schultz brings public company healthcare finance and medical technology experience to support Nuwellis’ next phase of growth","length":124,"tagName":"p"},{"type":"text","content":"MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026.","length":260,"tagName":"p"},{"type":"text","content":"Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including Associate Vice President, Enterprise Finance and Director, Finance.","length":501,"tagName":"p"},{"type":"text","content":"Ms. Schultz brings deep healthcare and medical technology finance experience, including early career experience at Boston Scientific, alongside leadership roles across public and private healthcare organizations. Her background also includes Big Four public accounting and senior financial analysis leadership roles supporting growth, operational discipline, and strategic decision-making.","length":389,"tagName":"p"},{"type":"text","content":"“Carisa is a highly accomplished financial leader with strong public-company experience and a deep understanding of healthcare and medical technology,” said John Erb, Chief Executive Officer of Nuwellis. “Her expertise and disciplined approach will be instrumental as we continue to execute our strategy and advance our cardiorenal platform.”","length":3...

More updates from Boston Scientific Corporation

Carisa SchultzNuwellis, Inc.Schultzleadership rolesNew York Stock Exchangehealthcaremedical technologyhealthcare companyChief Executive OfficerNuwellis Nuwellis, Inc.